United States : USFDA approves Dr. REDDYS's Duloxetine equivalent generic version of Eli Lillys Cymbalta.
United States Food & Drug Administration (USFDA) ratified Dr. Reddy's ANDA.
As per the IMS Health, CYMBALTAA brand and generic had U.S. sales of nearly $5.04 Billion MAT for the most recent twelve months ending in April 2014.
In various bottle counts, Dr. Reddy's Duloxetine Delayed-Release Capsules USP 20 mg, 30 mg and 60 mg are acquirable.
CYMBALTAA is a registered trademark of Eli Lilly and firm.
2014 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).
|Printer friendly Cite/link Email Feedback|
|Date:||Jul 1, 2014|
|Previous Article:||United States : VESTAS secures two contracts totaling 450MW.|
|Next Article:||United States : Simpson Thacher Represents Adeptus Health Inc. in Initial Public Offering.|